University of California, Irvine Program in Public Health professor of health, society and behavior Leigh Turner (IMAGE)
Caption
“Beyond the administration of stem cells to patients with cancer and selected immunological conditions, there is cautious optimism around the prospect of treating various other diseases and injuries with stem cell treatments and other regenerative medicine products,” says Leigh Turner, Ph.D., corresponding author and professor of health, society and behavior in the UCI Program in Public Health. “Stem cell therapy is still in its early stages and faces years of clinical trials and approvals to expand the list of approved, evidence-based therapy.”
Credit
Steve Zylius / UCI
Usage Restrictions
None
License
Original content